Oncology company Thyme Care raises $125M, backed by Morgan Health, Humana and CVS Health Ventures
Thyme Care landed a series E financing round of more than $125 million backed by strategic payers and providers as it aims to expand beyond cancer care navigation.
Useful signal?
Sign in with GitHub below to react 👍 / 👎, or comment if a category looks wrong — your reactions help curate this feed. How feedback works
Draft Insight Angle
Auto-generated draft — review and edit before any external use.
Humana, CVS Health — uncategorized. Via Fierce Healthcare.
Analytic angles
- Single-source so far — corroborate against a second outlet.
- Confirm the Medicare Advantage angle against a primary source.
Draft paragraph
[DRAFT — verify before any external use] Fierce Healthcare reports on uncategorized involving Humana, CVS Health: Thyme Care landed a series E financing round of more than $125 million backed by strategic payers and providers as it aims to expand beyond cancer care navigation.
Note: This is an early signal based on public reporting. Confirm against primary sources before drawing conclusions. Market dynamics may shift as additional information emerges.